8-K: Earth Science Tech Reports Record-Breaking Financial Results for Fiscal Year Ending March 31, 2025

Earth Science Tech, Inc. announces projected record-breaking financial results for the fiscal year ending March 31, 2025, including a 340% increase in net income and a 175% increase in revenue.

Summary

• Earth Science Tech, Inc. (ETST) released its annual shareholder letter for the fiscal year ending March 31, 2025.
• The company projects a net income of $3.6 million, a 340% increase year-over-year.
• Revenue is projected to surpass $32 million, representing a 175% increase.
• Earnings per share (EPS) are projected to be $0.01.
• Total assets are projected to increase to $7.2 million, an 85% growth compared to the prior fiscal year.
• The company repurchased 15,634,212 common shares in the latest fiscal year and subsequent period, bringing the total share reduction under the current $5m repurchase program to 20,834,214 at a cost of $1,830,617.71.
• The Board of directors expanded to 7 members, including 2 independent members.
• The company has qualified to have its shares listed on the new OTCID market beginning in July 2025.
• The company has 67 official employees with an additional 9 independent/temporary contractors.
• The company acquired Mister Meds, LLC, Avenvi, LLC, Las Villas Health Care, LLC, and Magnefuse, LLC.

Sentiment

Score: 9

Explanation: The document presents a highly positive outlook with record-breaking financial results and strategic acquisitions, indicating strong growth and potential for future success.

Positives

• The company projects significant growth in net income, revenue, and total assets.
• The company is expanding its operations through strategic acquisitions.
• The company is increasing its employee count.
• The company is expanding its board of directors to include independent members.
• The company has qualified to have its shares listed on the new OTCID market beginning in July 2025.
• The company repurchased 15,634,212 common shares in the latest fiscal year and subsequent period.

Risks

• The announcement includes forward-looking statements that are subject to risks and uncertainties.
• The company's actual results may differ materially from its projections.

Future Outlook

The company's strategy for the next fiscal year is to identify promising ventures, strengthen operational foundations, and pursue innovation. The company expresses confidence and momentum entering the new fiscal year.

Management Comments

• The CEO states that the past year has been a milestone period of growth, operational focus, and strategic execution.
• The CEO expresses pride and appreciation in presenting the 2024 Annual Shareholder Letter.
• The CEO states that the company's core mission remains to unlock value through operational excellence and smart capital stewardship.
• The CEO extends gratitude to shareholders for their continued trust and support.

Industry Context

The company operates in the strategic holding company sector, focusing on acquiring and optimizing operating businesses. The acquisitions of companies like RxCompoundStore, Peaks Curative, Mister Meds, Avenvi, Las Villas Health Care, and Magnefuse indicate a strategy of diversification across healthcare, real estate, and consumer retail.

Comparison to Industry Standards

• Comparing Earth Science Tech's projected revenue growth of 175% to other small-cap holding companies, this represents a substantial increase.
• For example, comparable companies in similar sectors often experience revenue growth in the range of 10-30% annually.
• The projected net income increase of 340% is also significantly higher than industry averages for companies of similar size.

Corporate Governance

Stakeholder Impact

• Shareholders are expected to benefit from the company's strong financial performance and strategic initiatives.
• Employees may benefit from increased job security and opportunities for advancement.
• Customers may benefit from expanded product offerings and improved services.

Next Steps

• The company intends to convert independent/temporary contractors into full-time employees or create in-house positions.
• Mister Meds facility in Abilene, Texas is expected to be live in the current quarter.
• Avenvi, LLC is currently in the permitting process for its first development.
• The company expects Magnefuse, LLC to ramp up and be a growth driver in the consumer retail space.
• The company will list on the new OTCID market beginning in July 2025.

Key Dates

Keywords

financial results, annual shareholder letter, acquisitions, revenue, net income, OTC, ETST, Earth Science Tech